147 related articles for article (PubMed ID: 20812024)
1. FBI-1 functions as a novel AR co-repressor in prostate cancer cells.
Cui J; Yang Y; Zhang C; Hu P; Kan W; Bai X; Liu X; Song H
Cell Mol Life Sci; 2011 Mar; 68(6):1091-103. PubMed ID: 20812024
[TBL] [Abstract][Full Text] [Related]
2. Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor.
Trtková K; Pašková L; Matiješčuková N; Kolář Z
Cancer Biomark; 2010; 7(2):79-90. PubMed ID: 21178266
[TBL] [Abstract][Full Text] [Related]
3. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
Yoon HG; Wong J
Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
[TBL] [Abstract][Full Text] [Related]
4. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
Hodgson MC; Astapova I; Hollenberg AN; Balk SP
Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755
[TBL] [Abstract][Full Text] [Related]
5. Ku is a novel transcriptional recycling coactivator of the androgen receptor in prostate cancer cells.
Mayeur GL; Kung WJ; Martinez A; Izumiya C; Chen DJ; Kung HJ
J Biol Chem; 2005 Mar; 280(11):10827-33. PubMed ID: 15640154
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor signaling: mechanism of interleukin-6 inhibition.
Jia L; Choong CS; Ricciardelli C; Kim J; Tilley WD; Coetzee GA
Cancer Res; 2004 Apr; 64(7):2619-26. PubMed ID: 15059919
[TBL] [Abstract][Full Text] [Related]
7. Unraveling androgen receptor interactomes by an array-based method: discovery of proto-oncoprotein c-Rel as a negative regulator of androgen receptor.
Mukhopadhyay NK; Ferdinand AS; Mukhopadhyay L; Cinar B; Lutchman M; Richie JP; Freeman MR; Liu BC
Exp Cell Res; 2006 Nov; 312(19):3782-95. PubMed ID: 17011549
[TBL] [Abstract][Full Text] [Related]
8. Binding of AR to SMRT/N-CoR complex and its co-operation with PSA promoter in prostate cancer cells treated with natural histone deacetylase inhibitor NaB.
Trtkova K; Paskova L; Matijescukova N; Strnad M; Kolar Z
Neoplasma; 2010; 57(5):406-14. PubMed ID: 20568894
[TBL] [Abstract][Full Text] [Related]
9. Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells.
Chen M; Feuerstein MA; Levina E; Baghel PS; Carkner RD; Tanner MJ; Shtutman M; Vacherot F; Terry S; de la Taille A; Buttyan R
Mol Cancer; 2010 Apr; 9():89. PubMed ID: 20420697
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor overexpression in prostate cancer linked to Pur alpha loss from a novel repressor complex.
Wang LG; Johnson EM; Kinoshita Y; Babb JS; Buckley MT; Liebes LF; Melamed J; Liu XM; Kurek R; Ossowski L; Ferrari AC
Cancer Res; 2008 Apr; 68(8):2678-88. PubMed ID: 18413735
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
12. Inability of NCoR/SMRT to repress androgen receptor transcriptional activity in prostate cancer cell lines.
Laschak M; Bechtel M; Spindler KD; Hessenauer A
Int J Mol Med; 2011 Oct; 28(4):645-51. PubMed ID: 21720703
[TBL] [Abstract][Full Text] [Related]
13. MEIS1 functions as a potential AR negative regulator.
Cui L; Li M; Feng F; Yang Y; Hang X; Cui J; Gao J
Exp Cell Res; 2014 Oct; 328(1):58-68. PubMed ID: 25158280
[TBL] [Abstract][Full Text] [Related]
14. Corepressor effect on androgen receptor activity varies with the length of the CAG encoded polyglutamine repeat and is dependent on receptor/corepressor ratio in prostate cancer cells.
Buchanan G; Need EF; Barrett JM; Bianco-Miotto T; Thompson VC; Butler LM; Marshall VR; Tilley WD; Coetzee GA
Mol Cell Endocrinol; 2011 Aug; 342(1-2):20-31. PubMed ID: 21664238
[TBL] [Abstract][Full Text] [Related]
15. Altered corepressor SMRT expression and recruitment to target genes as a mechanism that change the response to androgens in prostate cancer progression.
Godoy AS; Sotomayor PC; Villagran M; Yacoub R; Montecinos VP; McNerney EM; Moser M; Foster BA; Onate SA
Biochem Biophys Res Commun; 2012 Jul; 423(3):564-70. PubMed ID: 22695118
[TBL] [Abstract][Full Text] [Related]
16. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
17. Interaction of NCOR/SMRT Repressor Complexes with Papillomavirus E8^E2C Proteins Inhibits Viral Replication.
Dreer M; Fertey J; van de Poel S; Straub E; Madlung J; Macek B; Iftner T; Stubenrauch F
PLoS Pathog; 2016 Apr; 12(4):e1005556. PubMed ID: 27064408
[TBL] [Abstract][Full Text] [Related]
18. LINE-1 ORF-1p functions as a novel androgen receptor co-activator and promotes the growth of human prostatic carcinoma cells.
Lu Y; Feng F; Yang Y; Gao X; Cui J; Zhang C; Zhang F; Xu Z; Qv J; Wang C; Zeng Z; Zhu Y; Yang Y
Cell Signal; 2013 Feb; 25(2):479-89. PubMed ID: 23153584
[TBL] [Abstract][Full Text] [Related]
19. Regulation of a novel androgen receptor target gene, the cyclin B1 gene, through androgen-dependent E2F family member switching.
Li Y; Zhang DY; Ren Q; Ye F; Zhao X; Daniels G; Wu X; Dynlacht B; Lee P
Mol Cell Biol; 2012 Jul; 32(13):2454-66. PubMed ID: 22508987
[TBL] [Abstract][Full Text] [Related]
20. p68/DdX5 supports β-catenin & RNAP II during androgen receptor mediated transcription in prostate cancer.
Clark EL; Hadjimichael C; Temperley R; Barnard A; Fuller-Pace FV; Robson CN
PLoS One; 2013; 8(1):e54150. PubMed ID: 23349811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]